Cart (0 Items)
Your cart is currently empty.
View ProductsBrand | ProteoGenix |
---|---|
Product type | Elisa assay kits |
Size | 96T |
Product name | Ocaratuzumab ELISA Kit |
---|---|
Delivery condition | Blue ice (+4°) |
Storage condition | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
Brand | ProteoGenix |
Size | 96T |
Reference | KPTX179 |
Note | For research use only. |
Sample type | Plasma, Serum |
Immunogen | Ocaratuzumab |
Ocaratuzumab is a monoclonal antibody that has gained significant attention in the field of cancer research. It is a humanized IgG1 kappa antibody that specifically targets the CD20 antigen, which is highly expressed on the surface of B cells. Ocaratuzumab has shown promising results in the treatment of B-cell malignancies, making it a potential therapeutic target for various types of cancer.
The structure of Ocaratuzumab antibody is composed of two heavy chains and two light chains, each containing variable and constant regions. The variable regions of the heavy and light chains are responsible for the antigen-binding site, while the constant regions provide stability and effector functions. Ocaratuzumab has a molecular weight of approximately 148 kDa and is produced through recombinant DNA technology, ensuring high purity and consistency in its structure.
Ocaratuzumab antibody exerts its activity through multiple mechanisms, making it an effective therapeutic agent. Its primary mode of action is by binding to the CD20 antigen on the surface of B cells, leading to their destruction through various pathways, including complement-dependent cytotoxicity, antibody-dependent cellular cytotoxicity, and induction of apoptosis. Ocaratuzumab has also been shown to inhibit B-cell proliferation and induce cell cycle arrest, making it a potential treatment option for B-cell malignancies.
The Ocaratuzumab ELISA Kit is a cutting-edge tool that enables the detection and quantification of Ocaratuzumab antibody in various biological samples. This kit utilizes the enzyme-linked immunosorbent assay (ELISA) technique, which is widely used in scientific research and diagnostic laboratories due to its sensitivity, specificity, and ease of use. The Ocaratuzumab ELISA Kit is designed to detect both free and bound Ocaratuzumab antibody, providing a comprehensive analysis of its levels in a given sample.
The Ocaratuzumab ELISA Kit has a wide range of applications in the field of cancer research, including:
The Ocaratuzumab ELISA Kit is a powerful tool for detecting and studying Ocaratuzumab antibody, a promising therapeutic target for various types of cancer. Its high sensitivity, specificity, and ease of use make it a valuable asset for
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.